These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21555768)

  • 81. Isolation of multidrug-resistant Klebsiella oxytoca carrying blaIMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain.
    Conejo MC; Domínguez MC; López-Cerero L; Serrano L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2010 May; 65(5):1071-3. PubMed ID: 20215129
    [No Abstract]   [Full Text] [Related]  

  • 82. Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects.
    Joainig MM; Gorkiewicz G; Leitner E; Weberhofer P; Zollner-Schwetz I; Lippe I; Feierl G; Krause R; Hinterleitner T; Zechner EL; Högenauer C
    J Clin Microbiol; 2010 Mar; 48(3):817-24. PubMed ID: 20053860
    [TBL] [Abstract][Full Text] [Related]  

  • 83. New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).
    Granier SA; Leflon-Guibout V; Goldstein FW; Nicolas-Chanoine MH
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2922-8. PubMed ID: 12936995
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541.
    Miriagou V; Douzinas EE; Papagiannitsis CC; Piperaki E; Legakis NJ; Tzouvelekis LS
    Int J Antimicrob Agents; 2008 Dec; 32(6):540-1. PubMed ID: 18786812
    [No Abstract]   [Full Text] [Related]  

  • 85. Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.
    Rasheed JK; Biddle JW; Anderson KF; Washer L; Chenoweth C; Perrin J; Newton DW; Patel JB
    J Clin Microbiol; 2008 Jun; 46(6):2066-9. PubMed ID: 18385437
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
    Cagnacci S; Gualco L; Roveta S; Mannelli S; Borgianni L; Docquier JD; Dodi F; Centanaro M; Debbia E; Marchese A; Rossolini GM
    J Antimicrob Chemother; 2008 Feb; 61(2):296-300. PubMed ID: 18065411
    [TBL] [Abstract][Full Text] [Related]  

  • 89. NDM-1 Hazard in the Balkan States: Evidence of the First Outbreak of NDM-1-Producing Klebsiella pneumoniae in Bulgaria.
    Savov E; Politi L; Spanakis N; Trifonova A; Kioseva E; Tsakris A
    Microb Drug Resist; 2018 Apr; 24(3):253-259. PubMed ID: 28876169
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia.
    Sidjabat HE; Townsend KM; Hanson ND; Bell JM; Stokes HW; Gobius KS; Moss SM; Trott DJ
    J Antimicrob Chemother; 2006 May; 57(5):840-8. PubMed ID: 16524894
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Enterobacterial repetitive intergenic consensus 1R PCR assay for detection of Raoultella sp. isolates among strains identified as Klebsiella oxytoca in the clinical laboratory.
    Granier SA; Leflon-Guibout V; Goldstein FW; Nicolas-Chanoine MH
    J Clin Microbiol; 2003 Apr; 41(4):1740-2. PubMed ID: 12682174
    [TBL] [Abstract][Full Text] [Related]  

  • 92. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital.
    Kassis-Chikhani N; Decré D; Gautier V; Burghoffer B; Saliba F; Mathieu D; Samuel D; Castaing D; Petit JC; Dussaix E; Arlet G
    J Antimicrob Chemother; 2006 Jan; 57(1):142-5. PubMed ID: 16284103
    [TBL] [Abstract][Full Text] [Related]  

  • 93. First Report of Klebsiella oxytoca Strain Simultaneously Producing NDM-1, IMP-4, and KPC-2 Carbapenemases.
    Wang J; Yuan M; Chen H; Chen X; Jia Y; Zhu X; Bai L; Bai X; Fanning S; Lu J; Li J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674063
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
    Mikucionyte G; Zamorano L; Vitkauskiene A; López-Causapé C; Juan C; Mulet X; Oliver A
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):195-200. PubMed ID: 26638216
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
    Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
    Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
    [TBL] [Abstract][Full Text] [Related]  

  • 97. First description of KPC-2-producing Klebsiella oxytoca in Brazil.
    Almeida AC; Cavalcanti FL; Martins WM; Vilela MA; Gales AC; Morais Junior MA; Morais MM
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4077-8. PubMed ID: 23752512
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Bacteriological and Molecular Detection of
    Ahmed Hasan S; Mohammed Bakr M
    Arch Razi Inst; 2022 Oct; 77(5):1521-1525. PubMed ID: 37123151
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cytotoxic and pathogenic properties of Klebsiella oxytoca isolated from laboratory animals.
    Darby A; Lertpiriyapong K; Sarkar U; Seneviratne U; Park DS; Gamazon ER; Batchelder C; Cheung C; Buckley EM; Taylor NS; Shen Z; Tannenbaum SR; Wishnok JS; Fox JG
    PLoS One; 2014; 9(7):e100542. PubMed ID: 25057966
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Improved diagnosis of antibiotic-associated haemorrhagic colitis (AAHC) in faecal specimens by a new qualitative real-time PCR assay detecting relevant toxin genes of Klebsiella oxytoca sensu lato.
    Leitner E; Bozic M; Kienesberger S; Cosic A; Landt O; Högenauer C; Kessler HH
    Clin Microbiol Infect; 2022 May; 28(5):690-694. PubMed ID: 34582979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.